Reference
1. Townsend N, Wilson L, Bhatnagar P,
et al. Cardiovascular disease in Europe: epidemiological update 2016.
Eur Heart J, 2016, 37: 3232-3245.
2. Benjamin EJ, Blaha MJ, Chiuve SE,
et al. Heart Disease and Stroke Statistics-2017 Update: A Report From
the American Heart Association. Circulation, 2017, 135: e146-e603.
3. Shimoni S, Gendelman G, Ayzenberg
O, et al. Differential effects of coronary artery stenosis on myocardial
function: the value of myocardial strain analysis for the detection of
coronary artery disease. J Am Soc Echocardiogr, 2011, 24: 748-757.
4. Wang D, Zhang L, Zeng Q, et al.
Assessment of left ventricular performance in heart transplant
recipients by three-dimensional speckle tracking imaging. Medicine
(Baltimore), 2017, 96: e8129.
5. Nesser HJ, Mor-Avi V, Gorissen W,
et al. Quantification of left ventricular volumes using
three-dimensional echocardiographic speckle tracking: comparison with
MRI. Eur Heart J, 2009, 30: 1565-1573.
6. Zhou Q, Shen J, Liu Y, et al.
Assessment of left ventricular systolic function in patients with iron
deficiency anemia by three-dimensional speckle-tracking
echocardiography. Anatol J Cardiol, 2017, 18: 194-199.
7. Voilliot D, Huttin O, Hammache N,
et al. Impact of Global and Segmental Hypertrophy on Two-Dimensional
Strain Derived from Three-Dimensional Echocardiography in Hypertrophic
Cardiomyopathy: Comparison with Healthy Subjects. J Am Soc Echocardiogr,
2015, 28: 1093-1102.
8. Li L, Zhang PY, Ran H, et al.
Evaluation of left ventricular myocardial mechanics by three-dimensional
speckle tracking echocardiography in the patients with different graded
coronary artery stenosis. Int J Cardiovasc Imaging, 2017, 33: 1513-1520.
9. Montalescot G, Sechtem U, Achenbach
S, et al. 2013 ESC guidelines on the management of stable coronary
artery disease: the Task Force on the management of stable coronary
artery disease of the European Society of Cardiology. Eur Heart J, 2013,
34: 2949-3003.
10. Ryu KS, Park HW, Park SH, et al.
Comparison of clinical outcomes between culprit vessel only and
multivessel percutaneous coronary intervention for ST-segment elevation
myocardial infarction patients with multivessel coronary diseases. J
Geriatr Cardiol, 2015, 12: 208-217.
11. Solomon SD, Anavekar N, Skali H,
et al. Influence of ejection fraction on cardiovascular outcomes in a
broad spectrum of heart failure patients. Circulation, 2005, 112:
3738-3744.
12. Yip GW, Zhang Q, Xie JM, et al.
Resting global and regional left ventricular contractility in patients
with heart failure and normal ejection fraction: insights from
speckle-tracking echocardiography. Heart, 2011, 97: 287-294.
13. Langeland S, Wouters PF, Claus P,
et al. Experimental assessment of a new research tool for the estimation
of two-dimensional myocardial strain. Ultrasound Med Biol, 2006, 32:
1509-1513.
14. Leitman M, Lysyansky P, Sidenko
S, et al. Two-dimensional strain-a novel software for real-time
quantitative echocardiographic assessment of myocardial function. J Am
Soc Echocardiogr, 2004, 17: 1021-1029.
15. Biswas M, Sudhakar S, Nanda NC,
et al. Two- and three-dimensional speckle tracking echocardiography:
clinical applications and future directions. Echocardiography, 2013, 30:
88-105.
16. Thebault C, Donal E, Bernard A,
et al. Real-time three-dimensional speckle tracking echocardiography: a
novel technique to quantify global left ventricular mechanical
dyssynchrony. Eur J Echocardiogr, 2011, 12: 26-32.
17. Hayat D, Kloeckner M, Nahum J, et
al. Comparison of real-time three-dimensional speckle tracking to
magnetic resonance imaging in patients with coronary heart disease. Am J
Cardiol, 2012, 109: 180-186.
18. Tee M, Noble JA, Bluemke DA.
Imaging techniques for cardiac strain and deformation: comparison of
echocardiography, cardiac magnetic resonance and cardiac computed
tomography. Expert Rev Cardiovasc Ther, 2013, 11: 221-231.
19. Crosby J, Amundsen BH, Hergum T,
et al. 3-D speckle tracking for assessment of regional left ventricular
function. Ultrasound Med Biol, 2009, 35: 458-471.
20. Folmes CD, Sowah D, Clanachan AS,
et al. High rates of residual fatty acid oxidation during mild ischemia
decrease cardiac work and efficiency. J Mol Cell Cardiol, 2009, 47:
142-148.
21. Kane GC, Karon BL, Mahoney DW, et
al. Progression of left ventricular diastolic dysfunction and risk of
heart failure. Jama, 2011, 306: 856-863.
22. Nagueh SF, Smiseth OA, Appleton
CP, et al. Recommendations for the Evaluation of Left Ventricular
Diastolic Function by Echocardiography: An Update from the American
Society of Echocardiography and the European Association of
Cardiovascular Imaging. J Am Soc Echocardiogr, 2016, 29: 277-314.
23. Rydberg E, Willenheimer R,
Erhardt L. The prevalence of impaired left ventricular diastolic filling
is related to the extent of coronary atherosclerosis in patients with
stable coronary artery disease. Coron Artery Dis, 2002, 13: 1-7.
24. Nakatani S. Left ventricular
rotation and twist: why should we learn? J Cardiovasc Ultrasound, 2011,
19: 1-6.
25. Goffinet C, Chenot F, Robert A,
et al. Assessment of subendocardial vs. subepicardial left ventricular
rotation and twist using two-dimensional speckle tracking
echocardiography: comparison with tagged cardiac magnetic resonance. Eur
Heart J, 2009, 30: 608-617.
26. Reant P, Barbot L, Touche C, et
al. Evaluation of global left ventricular systolic function using
three-dimensional echocardiography speckle-tracking strain parameters. J
Am Soc Echocardiogr, 2012, 25: 68-79.
27. Wang Q, Gao Y, Tan K, et al.
Assessment of left ventricular function by three-dimensional
speckle-tracking echocardiography in well-treated type 2 diabetes
patients with or without hypertension. J Clin Ultrasound, 2015, 43:
502-511.
28. Chan J, Hanekom L, Wong C, et al.
Differentiation of subendocardial and transmural infarction using
two-dimensional strain rate imaging to assess short-axis and long-axis
myocardial function. J Am Coll Cardiol, 2006, 48: 2026-2033.
29. Kim HK, Sohn DW, Lee SE, et al.
Assessment of left ventricular rotation and torsion with two-dimensional
speckle tracking echocardiography. J Am Soc Echocardiogr, 2007, 20:
45-53.
30. Perk G, Tunick PA, Kronzon I.
Non-Doppler two-dimensional strain imaging by echocardiography–from
technical considerations to clinical applications. J Am Soc
Echocardiogr, 2007, 20: 234-243.
31. Kraigher-Krainer E, Shah AM,
Gupta DK, et al. Impaired systolic function by strain imaging in heart
failure with preserved ejection fraction. J Am Coll Cardiol, 2014, 63:
447-456.
32. Mizuguchi Y, Oishi Y, Miyoshi H,
et al. The functional role of longitudinal, circumferential, and radial
myocardial deformation for regulating the early impairment of left
ventricular contraction and relaxation in patients with cardiovascular
risk factors: a study with two-dimensional strain imaging. J Am Soc
Echocardiogr, 2008, 21: 1138-1144.
33. Nakai H, Takeuchi M, Nishikage T,
et al. Effect of aging on twist-displacement loop by 2-dimensional
speckle tracking imaging. J Am Soc Echocardiogr, 2006, 19: 880-885.
34. Winter R, Jussila R, Nowak J, et
al. Speckle tracking echocardiography is a sensitive tool for the
detection of myocardial ischemia: a pilot study from the catheterization
laboratory during percutaneous coronary intervention. J Am Soc
Echocardiogr, 2007, 20: 974-981.
35. Valli N, Gobinet A, Bordenave L.
Review of 10 years of the clinical use of brain natriuretic peptide in
cardiology. J Lab Clin Med, 1999, 134: 437-444.
36. Goetze JP, Jensen G, Moller S, et
al. BNP and N-terminal proBNP are both extracted in the normal kidney.
Eur J Clin Invest, 2006, 36: 8-15.
37. Hosoda K, Nakao K, Mukoyama M, et
al. Expression of brain natriuretic peptide gene in human heart.
Production in the ventricle. Hypertension, 1991, 17: 1152-1155.
38. Wei G, Yaqi R, Ningfu W, et al.
N-terminal prohormone B-type natriuretic peptide and cardiovascular risk
in stable coronary artery disease: a meta-analysis of nine prospective
studies. Rev Cardiovasc Med, 2013, 14: e92-98.
39. Eliasdottir SB, Klemenzson G,
Torfason B, et al. Brain natriuretic peptide is a good predictor for
outcome in cardiac surgery. Acta Anaesthesiol Scand, 2008, 52: 182-187.
40. Balta S, Demir M, Demirkol S, et
al. Plasma B-type natriuretic peptide level in patients with coronary
artery bypass surgery. Kaohsiung J Med Sci, 2013, 29: 648-649.
41. Chen TH, Lin CL, Shih JJ, et al.
Plasma B-type natriuretic peptide in predicting outcomes of elective
coronary artery bypass surgery. Kaohsiung J Med Sci, 2013, 29: 254-258.